(Q35094621)

6 August 2017

0 references

Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement (English)

1 reference

6 August 2017

1 reference

Dimitrios Christidis

1

1 reference

6 August 2017

Shaifali Jain

series ordinal

2

1 reference

6 August 2017

Bhaskar Das Gupta

series ordinal

3

1 reference

6 August 2017

publication date

30 June 2011

1 reference

6 August 2017

1 reference

6 August 2017

volume

2011

1 reference

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Disease pattern in cranial and large-vessel giant cell arteritis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Color duplex ultrasonography in the diagnosis of temporal arteritis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

BSR and BHPR guidelines for the management of polymyalgia rheumatica

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132621

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

27 September 2018

1 reference

12 December 2020

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial

1 reference

12 December 2020

Giant-cell arteritis producing an aortic arch syndrome

1 reference

12 December 2020

Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis

1 reference

12 December 2020

Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis

1 reference

12 December 2020

The sequential analysis of T lymphocyte subsets and interleukin-6 in polymyalgia rheumatica patients as predictors of disease remission and steroid withdrawal

1 reference

12 December 2020

Polymyalgia rheumatica and giant-cell arteritis

1 reference

12 December 2020

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

1 reference

12 December 2020

Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series

1 reference

12 December 2020

The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain

1 reference

12 December 2020

Identifiers

DOI

10.1136/BCR.04.2011.4135

1 reference

6 August 2017

1 reference

6 August 2017

1 reference